Market Closed -
Nyse
04:00:02 2024-05-24 pm EDT
|
5-day change
|
1st Jan Change
|
4.7
USD
|
+3.30%
|
|
-3.09%
|
-37.11%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,248
|
2,756
|
3,939
|
3,564
|
3,235
|
5,053
|
-
|
-
|
Enterprise Value (EV)
1 |
1,386
|
2,981
|
4,067
|
3,617
|
3,299
|
5,448
|
5,636
|
5,410
|
P/E ratio
|
25.1
x
|
-145
x
|
7,396
x
|
14.6
x
|
4.73
x
|
21.2
x
|
10.4
x
|
5.74
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.21
x
|
9.56
x
|
9.37
x
|
4.38
x
|
3.67
x
|
4.13
x
|
2.86
x
|
2.04
x
|
EV / Revenue
|
3.57
x
|
10.3
x
|
9.67
x
|
4.45
x
|
3.74
x
|
4.45
x
|
3.19
x
|
2.18
x
|
EV / EBITDA
|
13.9
x
|
134
x
|
58.5
x
|
9.86
x
|
6.57
x
|
10.5
x
|
6.95
x
|
3.97
x
|
EV / FCF
|
-11
x
|
-25.3
x
|
-38.5
x
|
30.7
x
|
-111
x
|
-22.4
x
|
-23
x
|
63.4
x
|
FCF Yield
|
-9.11%
|
-3.95%
|
-2.59%
|
3.26%
|
-0.9%
|
-4.46%
|
-4.35%
|
1.58%
|
Price to Book
|
2.29
x
|
4.87
x
|
5.48
x
|
2.78
x
|
0.68
x
|
0.8
x
|
0.73
x
|
0.71
x
|
Nbr of stocks (in thousands)
|
351,230
|
352,004
|
388,749
|
431,573
|
432,889
|
1,075,192
|
-
|
-
|
Reference price
2 |
3.554
|
7.830
|
10.13
|
8.259
|
7.473
|
4.700
|
4.700
|
4.700
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/14/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
388.4
|
288.2
|
420.4
|
813.2
|
882.5
|
1,225
|
1,765
|
2,477
|
EBITDA
1 |
99.8
|
22.3
|
69.5
|
366.7
|
502.5
|
519.4
|
810.5
|
1,362
|
EBIT
1 |
78.9
|
-2.7
|
44.4
|
339
|
472.9
|
338.6
|
632.4
|
1,086
|
Operating Margin
|
20.31%
|
-0.94%
|
10.56%
|
41.69%
|
53.59%
|
27.65%
|
35.83%
|
43.85%
|
Earnings before Tax (EBT)
1 |
57.8
|
-25.4
|
23.9
|
335.4
|
389
|
318.8
|
588.1
|
1,069
|
Net income
1 |
50.2
|
-18.9
|
0.6
|
273.5
|
330.1
|
241.9
|
498.3
|
879.1
|
Net margin
|
12.92%
|
-6.56%
|
0.14%
|
33.63%
|
37.41%
|
19.75%
|
28.23%
|
35.48%
|
EPS
2 |
0.1413
|
-0.0540
|
0.001370
|
0.5652
|
1.580
|
0.2219
|
0.4500
|
0.8188
|
Free Cash Flow
1 |
-126.2
|
-117.7
|
-105.5
|
117.8
|
-29.8
|
-242.8
|
-245.3
|
85.28
|
FCF margin
|
-32.49%
|
-40.84%
|
-25.1%
|
14.49%
|
-3.38%
|
-19.83%
|
-13.9%
|
3.44%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
32.12%
|
-
|
-
|
-
|
6.26%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
43.07%
|
-
|
-
|
-
|
9.7%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/14/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
122.9
|
143.5
|
218.7
|
231.6
|
219.4
|
253.5
|
235.8
|
211.4
|
181.8
|
261.2
|
278.8
|
562
|
329.9
|
355.1
|
706
|
383.4
|
401.6
|
EBITDA
1 |
27.5
|
53.3
|
95
|
110.8
|
107.6
|
157.4
|
134.5
|
119.7
|
90.9
|
108.8
|
105.8
|
215
|
131.1
|
150.9
|
262
|
166.2
|
176.3
|
EBIT
1 |
21.1
|
46.9
|
88.6
|
104.2
|
99.3
|
150.6
|
127.5
|
112
|
82.8
|
91.6
|
79.28
|
164
|
96.42
|
115.3
|
174
|
113.7
|
122.8
|
Operating Margin
|
17.17%
|
32.68%
|
40.51%
|
44.99%
|
45.26%
|
59.41%
|
54.07%
|
52.98%
|
45.54%
|
35.07%
|
28.44%
|
29.18%
|
29.23%
|
32.47%
|
24.65%
|
29.65%
|
30.56%
|
Earnings before Tax (EBT)
1 |
17
|
57.9
|
90.2
|
99.1
|
88.2
|
138.7
|
104.8
|
96.7
|
48.8
|
73.7
|
62.55
|
-
|
92.64
|
117.8
|
182
|
104.4
|
96.8
|
Net income
1 |
7.5
|
53.2
|
60
|
77.6
|
82.7
|
114.8
|
90.2
|
87.4
|
37.7
|
15.6
|
62.23
|
66
|
79.97
|
101.5
|
115
|
87.55
|
97.25
|
Net margin
|
6.1%
|
37.07%
|
27.43%
|
33.51%
|
37.69%
|
45.29%
|
38.25%
|
41.34%
|
20.74%
|
5.97%
|
22.32%
|
11.74%
|
24.24%
|
28.57%
|
16.29%
|
22.83%
|
24.22%
|
EPS
2 |
0.0166
|
0.1164
|
0.1288
|
0.1538
|
0.1621
|
0.2286
|
0.1787
|
0.1746
|
0.1800
|
0.0100
|
0.0543
|
-
|
0.0710
|
0.0890
|
-
|
0.0700
|
0.0750
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/17/22
|
5/3/22
|
8/2/22
|
11/1/22
|
2/14/23
|
5/2/23
|
8/3/23
|
10/31/23
|
2/22/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
138
|
225
|
127
|
52.9
|
64.4
|
394
|
582
|
357
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.381
x
|
10.09
x
|
1.833
x
|
0.1443
x
|
0.1282
x
|
0.7592
x
|
0.7187
x
|
0.2619
x
|
Free Cash Flow
1 |
-126
|
-118
|
-106
|
118
|
-29.8
|
-243
|
-245
|
85.3
|
ROE (net income / shareholders' equity)
|
9.71%
|
-2.65%
|
4.87%
|
24.4%
|
17.7%
|
3.07%
|
4.78%
|
8.23%
|
ROA (Net income/ Total Assets)
|
6.62%
|
-2.1%
|
0.06%
|
16.7%
|
12.4%
|
5.38%
|
5.89%
|
5.92%
|
Assets
1 |
757.9
|
898.2
|
1,070
|
1,638
|
2,652
|
4,500
|
8,457
|
14,841
|
Book Value Per Share
2 |
1.550
|
1.610
|
1.850
|
2.970
|
10.90
|
5.910
|
6.400
|
6.640
|
Cash Flow per Share
2 |
0.1600
|
0.0200
|
0.0600
|
0.9400
|
1.420
|
0.2600
|
0.4200
|
0.6700
|
Capex
1 |
189
|
124
|
132
|
337
|
327
|
620
|
713
|
607
|
Capex / Sales
|
48.66%
|
43.03%
|
31.37%
|
41.43%
|
37.07%
|
50.66%
|
40.38%
|
24.51%
|
Announcement Date
|
2/20/20
|
2/18/21
|
2/17/22
|
2/14/23
|
2/22/24
|
-
|
-
|
-
|
Average target price
8.097
USD Spread / Average Target +72.27% Consensus |
1st Jan change
|
Capi.
|
---|
| -37.11% | 5.05B | | +18.13% | 66.91B | | +3.65% | 49.8B | | +21.27% | 42.65B | | +22.79% | 26.61B | | +10.72% | 19.29B | | -1.61% | 16.7B | | +5.48% | 15.94B | | -29.11% | 14.43B | | -17.88% | 14.12B |
Other Specialty Chemicals
|